Eidelman Virant Capital purchased a new position in shares of UnitedHealth Group Inc (NYSE:UNH) during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor purchased 3,614 shares of the healthcare conglomerate’s stock, valued at approximately $881,000.

A number of other hedge funds have also modified their holdings of the business. Canton Hathaway LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at approximately $36,000. Truvestments Capital LLC purchased a new position in shares of UnitedHealth Group in the first quarter valued at approximately $42,000. Creative Financial Designs Inc. ADV lifted its position in shares of UnitedHealth Group by 89.6% in the first quarter. Creative Financial Designs Inc. ADV now owns 201 shares of the healthcare conglomerate’s stock valued at $50,000 after acquiring an additional 95 shares in the last quarter. Financial Gravity Wealth Inc. purchased a new position in shares of UnitedHealth Group in the first quarter valued at approximately $58,000. Finally, Horan Capital Advisors LLC. purchased a new position in shares of UnitedHealth Group in the first quarter valued at approximately $68,000. Institutional investors own 85.87% of the company’s stock.

Several equities research analysts recently commented on the company. UBS Group set a $36.00 price target on Halliburton and gave the company a “buy” rating in a report on Tuesday, April 23rd. Barclays set a $24.00 price target on Tenet Healthcare and gave the company a “hold” rating in a report on Wednesday, April 17th. Bank of America reaffirmed a “buy” rating and issued a C$10.00 price target on shares of Hexo in a report on Wednesday, April 17th. Zacks Investment Research raised Falcon Minerals from a “sell” rating to a “hold” rating in a research note on Monday, July 22nd. Finally, Morgan Stanley set a $207.00 target price on Alibaba Group and gave the stock a “buy” rating in a research note on Friday, July 12th. One investment analyst has rated the stock with a sell rating, one has issued a hold rating and eighteen have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $295.06.

In other news, CEO David S. Wichmann acquired 20,000 shares of the company’s stock in a transaction dated Friday, May 3rd. The stock was acquired at an average cost of $231.79 per share, with a total value of $4,635,800.00. Following the completion of the purchase, the chief executive officer now owns 904,367 shares of the company’s stock, valued at approximately $209,623,226.93. The acquisition was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director William C. Ballard, Jr. sold 5,000 shares of UnitedHealth Group stock in a transaction on Monday, May 6th. The shares were sold at an average price of $239.02, for a total value of $1,195,100.00. Following the completion of the sale, the director now directly owns 77,993 shares of the company’s stock, valued at $18,641,886.86. The disclosure for this sale can be found here. Insiders sold 37,000 shares of company stock valued at $9,158,720 over the last ninety days. Insiders own 0.82% of the company’s stock.

Shares of NYSE UNH traded up $1.18 during trading on Monday, reaching $254.12. The stock had a trading volume of 42,290 shares, compared to its average volume of 3,754,292. UnitedHealth Group Inc has a fifty-two week low of $208.07 and a fifty-two week high of $287.94. The company has a debt-to-equity ratio of 0.62, a quick ratio of 0.73 and a current ratio of 0.67. The stock has a 50-day moving average price of $250.74. The stock has a market capitalization of $240.38 billion, a P/E ratio of 19.73, a P/E/G ratio of 1.35 and a beta of 0.62.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, July 18th. The healthcare conglomerate reported $3.60 earnings per share for the quarter, beating the Zacks’ consensus estimate of $3.46 by $0.14. UnitedHealth Group had a return on equity of 25.20% and a net margin of 5.51%. The business had revenue of $60.60 billion during the quarter, compared to analysts’ expectations of $60.59 billion. During the same period in the previous year, the firm posted $3.14 earnings per share. The company’s revenue was up 8.0% on a year-over-year basis. Research analysts expect that UnitedHealth Group Inc will post 14.82 earnings per share for the current fiscal year.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Read More: How to trade on quiet period expirations

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.